Newton Sarah, Ding Yanli, Chung Chun-Shiang, Chen Yaping, Lomas-Neira Joanne L, Ayala Alfred
Division of Surgical Research, Department of Surgery, Lifespan/Rhode Island Hospital, Brown University School of Medicine, Providence, RI 02903, USA.
Surg Infect (Larchmt). 2004 Winter;5(4):375-83. doi: 10.1089/sur.2004.5.375.
Sepsis remains a substantial risk after surgery or other trauma. Macrophage dysfunction, as a component of immune suppression seen during trauma and sepsis, appears to be one of the contributing factors to morbidity and mortality. However, whereas it is known that the ability of macrophages to present antigen and express major histocompatibility complex MHC class II molecules is decreased during sepsis, it is not known to what extent this is associated with the loss of co-stimulatory receptor expression. Our objectives in this study were, therefore, to determine if the expression of co-stimulatory molecules, such as CD40, CD80, or CD86, on peritoneal/splenic/liver macrophages were altered by sepsis (cecal ligation [CL] and puncture [CLP] or necrotic tissue injury (CL) alone; and to establish the contribution of such changes to the response to septic challenge using mice that are deficient in these receptors.
To address our first objective, male C3H/HeN mice were subjected to CLP, CL, or sham (n = four to six mice/group), and the adherent macrophages were isolated from the peritoneum, spleen, or liver at 24 h post-insult. The macrophages were then analyzed by flow cytometry for their ex vivo expression of CD40, CD80, CD86, and/or MHC II.
The expression of CD86 and MHC II, but not CD40 or CD80, were significantly decreased on peritoneal macrophages after the onset of sepsis or CL alone. In addition, CD40 expression was significantly increased in Kupffer cells after sepsis. Alternatively, splenic macrophages from septic or CL mice did not show changes in the expression of CD80, CD86, or CD40. To the degree that the loss of CD86 expression might contribute to the changes reported in macrophage function in septic mice, we subsequently examined the effects of CLP on CD86 -/- mice. Interestingly, we found that, unlike the background controls, neither the serum IL-10 concentrations nor the IL-10 release capacity of peritoneal macrophages from septic CD86 -/- mice were increased.
Together, these data suggest a potential role for the co-stimulatory receptor CD86/B7-2 beyond that of simply promoting competent antigen presentation to T-cells, but also as a regulator of the anti-inflammatory IL-10 response. Such a role may implicate the latter response in the development of sepsis-induced immune dysfunction.
脓毒症仍是手术或其他创伤后的重大风险。巨噬细胞功能障碍作为创伤和脓毒症期间免疫抑制的一个组成部分,似乎是导致发病和死亡的因素之一。然而,虽然已知在脓毒症期间巨噬细胞呈递抗原和表达主要组织相容性复合体II类分子(MHC II)的能力会下降,但尚不清楚这在多大程度上与共刺激受体表达的丧失有关。因此,我们在本研究中的目标是确定脓毒症(盲肠结扎[CL]和穿刺[CLP]或仅坏死组织损伤[CL])是否会改变腹膜/脾脏/肝脏巨噬细胞上共刺激分子如CD40、CD80或CD86的表达;并使用缺乏这些受体的小鼠来确定这种变化对脓毒症挑战反应的影响。
为实现我们的第一个目标,将雄性C3H/HeN小鼠进行CLP、CL或假手术(每组4至6只小鼠),并在损伤后24小时从腹膜、脾脏或肝脏分离贴壁巨噬细胞。然后通过流式细胞术分析巨噬细胞体外CD40、CD80、CD86和/或MHC II的表达。
脓毒症发作后或仅CL后,腹膜巨噬细胞上CD86和MHC II的表达显著降低,但CD40或CD80没有。此外,脓毒症后库普弗细胞中CD40表达显著增加。另外,脓毒症或CL小鼠的脾脏巨噬细胞中CD80、CD86或CD40的表达没有变化。就CD86表达的丧失可能导致脓毒症小鼠巨噬细胞功能变化的程度而言,我们随后研究了CLP对CD86 -/-小鼠的影响。有趣的是,我们发现,与背景对照组不同,脓毒症CD86 -/-小鼠的血清IL-10浓度和腹膜巨噬细胞的IL-10释放能力均未增加。
总之,这些数据表明共刺激受体CD86/B7-2不仅在简单促进向T细胞呈递有效抗原方面具有潜在作用,而且还作为抗炎性IL-10反应的调节因子。这种作用可能与脓毒症诱导的免疫功能障碍的发展中的后者反应有关。